Stocks › RDY

DR REDDYS LABORATORIES LTD

RDY·NYSE·USD
$13.23
+0.04 (+0.30%)
Close · Oct 22, 2026 · Close Prices from Tiingo.com
RDY
DR REDDYS LABORATORIES LTD · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
RDYS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of RDY by members of U.S. Congress · 8 on record
All congressional trades →
PoliticianStockTypeFiledTraded
Michael T. McCaulMichael T. McCaulHouse · R · TX RDYDR REDDYS LABORATORIES LTD · Stock Sale
$15,001 - $50,000
Nov 19, 2015 Oct 12, 2015 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX RDYDR REDDYS LABORATORIES LTD · Stock Sale
$15,001 - $50,000
Nov 19, 2015 — Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX RDYDR REDDYS LABORATORIES LTD · Stock Sale
$15,001 - $50,000
Nov 14, 2014 Oct 2, 2014 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX RDYDR REDDYS LABORATORIES LTD · Stock Sale
$15,001 - $50,000
Nov 14, 2014 Oct 2, 2014 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX RDYDR REDDYS LABORATORIES LTD · Stock Purchase
$50,001 - $100,000
Apr 10, 2014 Mar 21, 2014 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX RDYDR REDDYS LABORATORIES LTD · Stock Purchase
$100,001 - $250,000
Apr 10, 2014 Mar 21, 2014 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX RDYDR REDDYS LABORATORIES LTD · Stock Purchase
$50,001 - $100,000
Feb 12, 2014 Jan 3, 2014 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX RDYDR REDDYS LABORATORIES LTD · Stock Purchase
$50,001 - $100,000
Feb 12, 2014 Jan 3, 2014 Filing ↗

Whale Activity

Position changes in RDY reported for 2026-06-30 by 8 tracked institutional filers
Increased: 1Held: 1Decreased: 5Closed: 1
  • Increased1
  • New0
  • Held1
  • Decreased5
  • Closed1
  • No prior filing0
FilerSharesValueChange
BlackRock, Inc.10.6M$153.4Mdecreased
RENAISSANCE TECHNOLOGIES LLC7.3M$106.5Mdecreased
VANGUARD CAPITAL MANAGEMENT LLC3.1M$44.9Mheld
VANGUARD PORTFOLIO MANAGEMENT LLC1.5M$22.1Mdecreased
MILLENNIUM MANAGEMENT LLC468.4K$6.8Mincreased
D. E. Shaw & Co., Inc.126.5K$1.8Mdecreased
CITADEL ADVISORS LLC79.2K$1.1Mdecreased
Two Sigma Investments, LP0$0closed

KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.

Insider Trading

Net shares bought (+) or sold (−) on the open market by RDY insiders, by quarter · Form 4

No open-market insider buys or sells in the last two years.

Recent Insider Transactions

0 transactions on record · newest first
All insider activity →

No insider transactions on record.

Fund Holders

Mutual funds and ETFs holding RDY · SEC Form N-PORT
FundSharesValue% of fundAs of
AB Emerging Markets Opportunities ETF
AB Active ETFs, Inc.
3.7M$53.9M2.54%Jun 30, 2026
College Retirement Equities Fund - Total Global Stock Account
College Retirement Equities Fund
2.0M$29.4M0.02%Jun 30, 2026
Avantis Emerging Markets Equity ETF
American Century ETF Trust
1.7M$23.4M0.09%May 31, 2026
State Street(R) SPDR(R) Portfolio Emerging Markets ETF
SPDR INDEX SHARES FUNDS
1.5M$21.2M0.12%Jun 30, 2026
EMERGING MARKETS CORE EQUITY 2 PORTFOLIO
DFA INVESTMENT DIMENSIONS GROUP INC
1.4M$16.0M0.04%Jul 31, 2026
Nuveen Emerging Markets Equity Fund
TIAA-CREF Funds
739.1K$8.8M0.49%Jul 31, 2026
Templeton Emerging Markets Equity Fund
Templeton Developing Markets Trust
489.8K$7.1M0.26%Jun 30, 2026
SIT Emerging Markets Equity Fund
SEI INSTITUTIONAL INTERNATIONAL TRUST
476.7K$6.9M0.39%Jun 30, 2026
THE EMERGING MARKETS SERIES
DFA INVESTMENT TRUST CO
511.9K$6.1M0.07%Jul 31, 2026
DIMENSIONAL EMERGING MARKETS VALUE FUND420.8K$5.0M0.03%Jul 31, 2026

Mutual funds and ETFs whose N-PORT filings list RDY's shares (CUSIP 256135203), each fund at its latest report since Mar 24, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings

No 13D/13G beneficial-ownership filings on record.

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming DR REDDYS LABORATORIES LTD as client

No lobbying filings found naming DR REDDYS LABORATORIES LTD as the client.

Government Contracts

Federal awards to DR REDDYS LABORATORIES LTD · USAspending

No federal contract awards found for DR REDDYS LABORATORIES LTD.

U.S. Patents

Recent USPTO applications naming DR REDDYS LABORATORIES LTD

No USPTO patent applications found for DR REDDYS LABORATORIES LTD.

Annual Financials

From RDY's 10-K filings · XBRL

No annual XBRL figures on record for RDY. KeyVex's fundamentals cover about 130 large companies so far.

Stock Splits

Every split and reverse split in the price history
  • 5-for-1Stock splitNov 5, 2024
  • 2-for-1Stock splitSep 7, 2006

Split dates and ratios from the price history · Close Prices from Tiingo.com

Material Events (8-K)

Corporate events filed with the SEC

No 8-K filings on record.

About DR REDDYS LABORATORIES LTD

From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersHYDERABAD
IncorporatedK7